Blood test may predict lung transplant or death risk in PH patients
NCT ID NCT07253363
First seen Jan 05, 2026 · Last updated May 29, 2026 · Updated 28 times
Summary
This study is looking at two substances in the blood, called Activin-A and FSTL3, to see if they can help predict how people with pulmonary hypertension will do over time. Researchers will follow 550 adults with different types of this condition to see if these markers are linked to the need for a lung transplant or death within two years. The goal is to better understand the disease and improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Bicêtre (AP-HP.Université Paris-Saclay), Service de Pneumologie et Soins Intensifs
Le Kremlin-Bicêtre, France, 94270, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.